TECHNOLOGY

With our proprietary protein-protein conjugation technology, UniStac, we develop highly potent tri- or tetraspecific protein-based drug. It allows unlimited combination of different type of molecules, such as Fab fragment, scFv, sdAb, peptide, cytokines, agonist/antagonist, or enzymes. The unprecedented design flexibility with optimized physical properties opens new design space of multispecific protein drug with CMC feasibility.